Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Chiral Chromatography Column
... at a CAGR of 3.7% over the analysis period 2024-2030. Pharmaceutical & Biotechnology End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$54.2 Million by the ... Read More
-
Chromatographic Silica Resins
... at a CAGR of 3.6% over the analysis period 2024-2030. Ultrapure Silica (Up To 99%) Chromatographic Silica Resins, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification Technique, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis ... Read More
-
Electrochemical Instruments
... CAGR of 4.7% over the analysis period 2024-2030. Electrochemical Meters, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Nanomedicine
... 9.7% over the analysis period 2024-2030. Nanomedicine Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$442.7 Billion by the end of the analysis period. Growth ... Read More
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of ... Read More
-
Medical Composites
... CAGR of 8.4% over the analysis period 2024-2030. Ceramic Fiber Composites, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
NGS-Based RNA-Sequencing
... CAGR of 20.1% over the analysis period 2024-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Protein Expression
... CAGR of 13.0% over the analysis period 2024-2030. Protein Expression Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.6 Billion by the end of the ... Read More
-
Renal Biomarkers
... CAGR of 6.5% over the analysis period 2024-2030. Functional Biomarkers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Molecular Weight Markers
... at a CAGR of 11.4% over the analysis period 2024-2030. DNA Markers, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$896.3 Million by the end of ... Read More
-
Serological Transplant Diagnostics
... at a CAGR of 8.6% over the analysis period 2024-2030. Serological Transplant Diagnostic Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion ... Read More
-
Single-Use Bioreactors
... CAGR of 15.1% over the analysis period 2024-2030. Single-Use Bioreactor Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$6.1 Billion by the end of the ... Read More
-
Human Identification
... CAGR of 7.7% over the analysis period 2024-2030. Human Identification Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end ... Read More
-
Human Liver Models
... at a CAGR of 9.3% over the analysis period 2024-2030. Liver Organoids, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$250.6 Million by the end of ... Read More
-
Biotech Equipment Update February 2025
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information. Read More
-
Biotech Business February 2025
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Bone Morphogenetic Proteins
... at a CAGR of 2.4% over the analysis period 2024-2030. Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$484.6 Million ... Read More
-
Microbial Fermentation Technology
... at a CAGR of 5.3% over the analysis period 2024-2030. Antibiotics Application, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$16.2 Billion by the end of ... Read More
-
Photopheresis Products
... CAGR of 5.4% over the analysis period 2024-2030. Open System, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$164.4 Million by the end of the analysis ... Read More
-
Plasma Protein Therapeutics
... at a CAGR of 4.8% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$9.3 Billion by the end of the ... Read More
-
SNP Genotyping and Analysis
... 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach ... Read More
-
Nanobiotechnology
... 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Immunofluorescence Assay Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the ... Read More
Research Assistance
